Company intelligence / Profile preview
GemVax & KAEL Co., Ltd.
Daejeon, Daejeon, South Koreagemvax.com ↗
- Ownership
- Private
- Development stage
- Phase 2
01
Overview
GV1001 missed the primary endpoint in a Phase 2a study for Progressive Supranuclear Palsy (PSP) in October 2024, but the company believes the overall data is strong enough to consider advancing to a pivotal trial. The company is also conducting a Phase 2 trial for Alzheimer's disease in the US and Europe. Their pancreatic cancer drug RIAVAX (GV1001) received conditional approval in South Korea in 2014, but this was later revoked in 2020 when the company failed to submit required Phase 3 clinical results.[6][9]
- Therapeutic areas
- Men's HealthOncologyImmunologyNeurology
- Modalities
- Synthetic peptidesTherapeutic vaccinesSynthetic peptide vaccines
- Industry
- Biotech
02
Drug pipeline
4 assets3 more assets in the full pipeline.
Request access →03
Partnerships
Samsung Pharm Co., Ltd.
Beyond the preview
Go deeper on GemVax & KAEL Co., Ltd..
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on GemVax & KAEL Co., Ltd..